Clinical actions of fentanyl and buprenorphine. The significance of receptor binding.
Receptor binding assays were undertaken in an attempt to elucidate the opioid binding characteristics of fentanyl and buprenorphine, and to investigate some of the differences between them. Buprenorphine showed slow receptor association (30 min), but with high affinity to multiple sites from which dissociation was very slow (T 1/2 = 166 min) and incomplete (50% binding after 1 h). This contrasted with the receptor binding of fentanyl, which achieved rapid equilibrium (within 10 min) and dissociated equally rapidly (T 1/2 = 6.8 min) and completely (100% by 1 h). Competitive displacement showed buprenorphine displacement of fentanyl binding was concentration- and time-dependent over ranges encountered in clinical use, but buprenorphine binding was displaced with only very high concentrations of other opioids. These findings offer pharmacodynamic explanations for the differences in fentanyl and buprenorphine analgesic response profiles and suggest how binding interactions might be applied to therapeutic use.
Boas
R A
RA
Villiger
J W
JW
D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism; D002047:Buprenorphine / Q000378:metabolism*; D005283:Fentanyl / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D009019:Morphinans / Q000378:metabolism*; D011869:Radioligand Assay; D051381:Rats; D011919:Rats, Inbred Strains; D011957:Receptors, Opioid / Q000378:metabolism*; D013997:Time Factors
D009019:Morphinans; D011957:Receptors, Opioid; D002047:Buprenorphine; D005283:Fentanyl